Literature DB >> 29121124

Atopic dermatitis prevention and treatment.

Nanette B Silverberg1.   

Abstract

Atopic dermatitis (AD) is the cause of substantial morbidity including severe pruritus and impaired personal and familial quality of life. Furthermore, the rising incidence and familial association of AD have highlighted the need for disease prevention. It is largely genetic in nature and cannot be avoided in all cases. However, low-risk prevention strategies have been attempted to reduce triggering of first onset of AD in predisposed individuals. Therapeutics for active disease include trigger avoidance, barrier repair, topical medicaments including topical corticosteroids (TCs) and nonsteroidal agents, phototherapy, and antibacterial interventions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29121124

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  4 in total

1.  Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis.

Authors:  Farnam B Sedeh; Mattias A S Henning; Gregor B E Jemec; Kristina S Ibler
Journal:  Acta Derm Venereol       Date:  2022-08-24       Impact factor: 3.875

Review 2.  Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis.

Authors:  Rhea Singh; Courtney E Heron; Rima I Ghamrawi; Lindsay C Strowd; Steven R Feldman
Journal:  Immunotargets Ther       Date:  2020-11-10

3.  Halting the March: Primary Prevention of Atopic Dermatitis and Food Allergies.

Authors:  Fatima Bawany; Lisa A Beck; Kirsi M Järvinen
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03

Review 4.  Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection.

Authors:  Anna B Fishbein; Jonathan I Silverberg; Eve J Wilson; Peck Y Ong
Journal:  J Allergy Clin Immunol Pract       Date:  2019-08-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.